4,979 reports of this reaction
1.5% of all DICLOFENAC SODIUM TOPICAL GEL, 1% reports
#14 most reported adverse reaction
HAND DEFORMITY is the #14 most commonly reported adverse reaction for DICLOFENAC SODIUM TOPICAL GEL, 1%, manufactured by BluePoint Laboratories. There are 4,979 FDA adverse event reports linking DICLOFENAC SODIUM TOPICAL GEL, 1% to HAND DEFORMITY. This represents approximately 1.5% of all 323,718 adverse event reports for this drug.
Patients taking DICLOFENAC SODIUM TOPICAL GEL, 1% who experience hand deformity should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HAND DEFORMITY is a less commonly reported adverse event for DICLOFENAC SODIUM TOPICAL GEL, 1%, but still significant enough to appear in the safety profile.
In addition to hand deformity, the following adverse reactions have been reported for DICLOFENAC SODIUM TOPICAL GEL, 1%:
The following drugs have also been linked to hand deformity in FDA adverse event reports:
HAND DEFORMITY has been reported as an adverse event in 4,979 FDA reports for DICLOFENAC SODIUM TOPICAL GEL, 1%. This does not prove causation, but indicates an association observed in post-market surveillance data.
HAND DEFORMITY accounts for approximately 1.5% of all adverse event reports for DICLOFENAC SODIUM TOPICAL GEL, 1%, making it a notable side effect.
If you experience hand deformity while taking DICLOFENAC SODIUM TOPICAL GEL, 1%, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.